Lenacapavir - HIV Prevention

Learn about lenacapavir, a groundbreaking HIV prevention medication, in this 24-minute educational presentation delivered by Dr. Rebecca Reece through the WVCTSI Project ECHO HIV Prevention program. Explore the mechanism of action, clinical efficacy, dosing protocols, and practical implementation considerations for this innovative long-acting injectable HIV prevention option. Gain insights into how lenacapavir fits into current HIV prevention strategies, its advantages over existing pre-exposure prophylaxis (PrEP) options, patient selection criteria, and real-world application in clinical practice. Understand the latest research findings, safety profile, and potential impact of this medication on HIV prevention efforts, particularly for populations who may benefit from long-acting formulations that reduce the burden of daily oral medication adherence.